Skip to main content
Top
Published in: Israel Journal of Health Policy Research 1/2016

Open Access 01-12-2016 | Original research article

The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study

Authors: Dvora Frankenthal, Gisele Zandman-Goddard, Yael Ben-Muvhar, Bat Sheva Porat-Katz

Published in: Israel Journal of Health Policy Research | Issue 1/2016

Login to get access

Abstract

Background

Antipsychotic medications (APMs) are commonly prescribed in nursing homes (NHs) and their excessive use raises concerns about the quality of care. They are often seen as “chemical restraints”, and were shown to increase morbidity and mortality risks in NH residents. The objective of this study was to investigate the variability in prevalence in APM use in a sample of Israeli NHs and to examine the effect of facility characteristics on the use of APMs.

Methods

A retrospective cross-sectional study was conducted in 2011 using data which were collected in a sample of NHs in the Tel Aviv district during the annual certification process. Prevalence of APMs was determined on the basis of all residents using antipsychotics on a regular basis. The association between facility characteristics and APM use was assessed by multivariate analysis.

Results

Forty-four NHs providing care for 2372 residents were investigated. The prevalence of APM use varied between facilities from 14.8 to 70.6 %, with an overall prevalence of 37.3 %. Multiple linear regression analysis revealed that greater use of APMs was associated with for-profit facilities, facilities in which most of the residents were self-pay, the presence of a “mentally frail” unit, a medical director non-specialized in geriatrics, shortage of social workers and occupational therapists, presence of unsafe/non-fitting equipment or self-aids (e.g., unsafe bath/toilet seats, unsuitable height of tables) and shortage of recreational activities.

Conclusions

A wide variation in APM use was recorded in NHs in the Tel Aviv district. This variation was associated with facility characteristics that undermine quality of care. Application of APM use as a measure of quality in NHs and publicizing their utilization may decrease their overall use.
Literature
1.
go back to reference Kleijer BC, van Marum RJ, Frijters DH, Jansen PA, Ribbe MW, Egberts AC, et al. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. Int Psychogeriatr. 2014;26:363–71.CrossRefPubMed Kleijer BC, van Marum RJ, Frijters DH, Jansen PA, Ribbe MW, Egberts AC, et al. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. Int Psychogeriatr. 2014;26:363–71.CrossRefPubMed
2.
go back to reference Lucas JA, Chakravarty S, Bowblis JR, Gerhard T, Kalay E, Paek EK, et al. Antipsychotic medication use in nursing homes: a proposed measure of quality. Int J Geriatr Psychiatry. 2014;29:1049–61.CrossRefPubMed Lucas JA, Chakravarty S, Bowblis JR, Gerhard T, Kalay E, Paek EK, et al. Antipsychotic medication use in nursing homes: a proposed measure of quality. Int J Geriatr Psychiatry. 2014;29:1049–61.CrossRefPubMed
3.
go back to reference Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167:676–83.CrossRefPubMed Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167:676–83.CrossRefPubMed
4.
go back to reference Foebel AD, Liperoti R, Onder G, Finne-Soveri H, Henrard JC, Lukas A, SHELTER Study Investigators, et al. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study. J Am Med Dir Assoc. 2014;15:911–7.CrossRefPubMed Foebel AD, Liperoti R, Onder G, Finne-Soveri H, Henrard JC, Lukas A, SHELTER Study Investigators, et al. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study. J Am Med Dir Assoc. 2014;15:911–7.CrossRefPubMed
5.
go back to reference Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009;26:483–92.CrossRefPubMed Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009;26:483–92.CrossRefPubMed
6.
go back to reference Briesacher BA, Limcangco MR, Simoni-Wastila L, Doshi JA, Levens SR, Shea DG, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165:1280–5.CrossRefPubMed Briesacher BA, Limcangco MR, Simoni-Wastila L, Doshi JA, Levens SR, Shea DG, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165:1280–5.CrossRefPubMed
7.
go back to reference Kolanowski A, Fick DM, Buettner L. Recreational activities to reduce behavioural symptoms in dementia. Geriatr Aging. 2009;12:37–42.PubMedPubMedCentral Kolanowski A, Fick DM, Buettner L. Recreational activities to reduce behavioural symptoms in dementia. Geriatr Aging. 2009;12:37–42.PubMedPubMedCentral
8.
go back to reference Camp CJ, Cohen-Mansfield J, Capezuti EA. Use of nonpharmacologic interventions among nursing home residents with dementia. Psychiatr Serv. 2002;53:1397–401. Review.CrossRefPubMed Camp CJ, Cohen-Mansfield J, Capezuti EA. Use of nonpharmacologic interventions among nursing home residents with dementia. Psychiatr Serv. 2002;53:1397–401. Review.CrossRefPubMed
9.
go back to reference Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010;170:89–95.CrossRefPubMedPubMedCentral Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010;170:89–95.CrossRefPubMedPubMedCentral
10.
go back to reference de Mauleon A, Sourdet S, Renom-Guiteras A, Gillette-Guyonnet S, Leino-Kilpi H, Karlsson S, RightTimePlaceCare Consortium, et al. Associated factors with antipsychotic use in long-term institutional care in eight European countries: Results from the RightTimePlaceCare study. J Am Med Dir Assoc. 2014;15:812–8.CrossRefPubMed de Mauleon A, Sourdet S, Renom-Guiteras A, Gillette-Guyonnet S, Leino-Kilpi H, Karlsson S, RightTimePlaceCare Consortium, et al. Associated factors with antipsychotic use in long-term institutional care in eight European countries: Results from the RightTimePlaceCare study. J Am Med Dir Assoc. 2014;15:812–8.CrossRefPubMed
11.
go back to reference Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy. 2015;119:802–13. Review.CrossRefPubMed Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy. 2015;119:802–13. Review.CrossRefPubMed
12.
go back to reference Hughes CM, Lapane KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care. 2000;38:1164–73.CrossRefPubMed Hughes CM, Lapane KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care. 2000;38:1164–73.CrossRefPubMed
13.
go back to reference Mukamel DB. Risk-adjusted outcome measures and quality of care in nursing homes. Med Care. 1997;35:367–85.CrossRefPubMed Mukamel DB. Risk-adjusted outcome measures and quality of care in nursing homes. Med Care. 1997;35:367–85.CrossRefPubMed
14.
go back to reference Hillmer MP, Wodchis WP, Gill SS, Anderson GM, Rochon PA. Nursing home profit status and quality of care: is there any evidence of an association? Med Care Res Rev. 2005;62:139–66. Review.CrossRefPubMed Hillmer MP, Wodchis WP, Gill SS, Anderson GM, Rochon PA. Nursing home profit status and quality of care: is there any evidence of an association? Med Care Res Rev. 2005;62:139–66. Review.CrossRefPubMed
15.
go back to reference Aaronson WE, Zinn JC, Rosko MD. Do for-profit and not for-profit nursing homes behave differently? Gerontologist. 1994;34:775–86.CrossRefPubMed Aaronson WE, Zinn JC, Rosko MD. Do for-profit and not for-profit nursing homes behave differently? Gerontologist. 1994;34:775–86.CrossRefPubMed
16.
go back to reference Azermai M, Elseviers M, Petrovic M, van Bortel L, Stichele RV. Assessment of antipsychotic prescribing in Belgain nursing homes. Int Psychogeriatr. 2011;23:1240–8.CrossRefPubMed Azermai M, Elseviers M, Petrovic M, van Bortel L, Stichele RV. Assessment of antipsychotic prescribing in Belgain nursing homes. Int Psychogeriatr. 2011;23:1240–8.CrossRefPubMed
17.
go back to reference Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians' prescription behavior. Int Psychogeriatr. 2011;23:1632–9.CrossRefPubMed Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians' prescription behavior. Int Psychogeriatr. 2011;23:1632–9.CrossRefPubMed
18.
go back to reference Putman L, Wang JT. The Closing Group: Therapeutic recreation for nursing home residents with dementia and accompanying agitation and/or anxiety. Am J Alzheimers Dis Other Demen. 2007;22:167–75.CrossRefPubMed Putman L, Wang JT. The Closing Group: Therapeutic recreation for nursing home residents with dementia and accompanying agitation and/or anxiety. Am J Alzheimers Dis Other Demen. 2007;22:167–75.CrossRefPubMed
19.
go back to reference Vernooij-Dassen M, Vasse E, Zuidema S, Cohen-Mansfield J, Moyle W. Psychosocial interventions for dementia patients in long-term care. Int Psychogeriatr. 2010;22:1121–8.CrossRefPubMed Vernooij-Dassen M, Vasse E, Zuidema S, Cohen-Mansfield J, Moyle W. Psychosocial interventions for dementia patients in long-term care. Int Psychogeriatr. 2010;22:1121–8.CrossRefPubMed
20.
go back to reference Liperati R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry. 2003;64:1106–12.CrossRef Liperati R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry. 2003;64:1106–12.CrossRef
21.
go back to reference Ellis ML, Molinari V, Dobbs D, Smith K, Hyer K. Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes. Aging Ment Health. 2015;19:507–16.CrossRefPubMed Ellis ML, Molinari V, Dobbs D, Smith K, Hyer K. Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes. Aging Ment Health. 2015;19:507–16.CrossRefPubMed
22.
go back to reference Finne-Saveri. Measuring the quality of long-term institutional care in Finland. Eurohealth. 2010;16:8. Finne-Saveri. Measuring the quality of long-term institutional care in Finland. Eurohealth. 2010;16:8.
Metadata
Title
The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study
Authors
Dvora Frankenthal
Gisele Zandman-Goddard
Yael Ben-Muvhar
Bat Sheva Porat-Katz
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2016
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-016-0070-y

Other articles of this Issue 1/2016

Israel Journal of Health Policy Research 1/2016 Go to the issue